20 employees
Leucid is progressing novel cart therapies that produce a better and more durable response.
2014
$16M
from 5 investors over 5 rounds
LEUCID BIO raised $16M on October 21, 2021
Investors: 2invest financial, Sofinnova Partners, Epidarex Capital, British Business Bank and Vulpes Investment Management